MIRA
INFORM REPORT
|
Report Date : |
27th
January, 2007 |
IDENTIFICATION
DETAILS
|
Name : |
ALPHA CHEM ADVANCED PHARMACEUTICAL INDUSTRY |
|
|
|
|
Registered Office : |
92 El Hegaz Street, Heliopolis, Cairo, Egypt. |
|
|
|
|
Country : |
Egypt |
|
|
|
|
Date of Incorporation : |
1995 |
|
|
|
|
Legal Form : |
Societe
Anonyme Egyptienne – SAE (Egyptian Joint Stock Company) |
|
|
|
|
Line of Business : |
Engaged in the manufacture and export of human pharmaceuticals. |
RATING & COMMENTS
|
MIRA’s Rating : |
Aa |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
71-85 |
Aa |
Possesses adequate working capital. No
caution needed for credit transaction. It has above average (strong)
capability for payment of interest and principal sums |
Large |
|
Maximum Credit Limit : |
US$
750,000 |
|
|
|
|
Status : |
Good |
|
|
|
|
Payment Behaviour : |
Regular |
|
|
|
|
Litigation : |
Clear |
SUMMARY
|
Company
Name |
ALPHA CHEM ADVANCED PHARMACEUTICAL INDUSTRY |
|
Country
of Origin |
Egypt |
|
Legal
Form |
Egyptian Joint Stock Company |
|
Registration
Date |
1995 |
|
Issued
Capital |
£E 27,500,000 |
|
Paid
up Capital |
£E 27,500,000 |
|
Total
Workforce |
350 |
|
Line
of Business |
Manufacture and export of human pharmaceuticals. |
|
Financial
Condition |
Undetermined |
|
Payments |
Nothing detrimental uncovered |
COMPANY NAME
ALPHA CHEM ADVANCED PHARMACEUTICAL INDUSTRY
ADDRESS
Registered & Physical Address
Street : 92 El
Hegaz Street
Area : Heliopolis
Town : Cairo
Country : Egypt
Telephone : (20-2) 2410940
/ 2419612
Facsimile : (20-2) 6343987
Premises
Subject
operates from a large suite of offices that are rented and located in the
Central Business Area of Cairo.
Branch Office (s)
Location Description
· 3rd
Industrial Zone, 1st Desert Road Owned
factory premises
Badr
City
Cairo
Tel: (20-2)
8640012 / 8640013 / 8640014
Fax: (20-2)
8640003
KEY PRINCIPALS
· Dr. George Sabet
Bassily Chairman
· Dr. Samir Ernest
Sadek Vice
Chairman
· Dr. Ezzat Halim
Boutros Director
· Ihab Sobhi Finance
Manager
· Dr. George Abd El
Shahid Factory
Manager
· Dr. Emeil Tadrous Marketing
Manager
· Ayman Adeeb Purchasing
Manager
LEGAL FORM & OWNERS
Date of Establishment : 1995
Legal Form : Societe Anonyme Egyptienne – SAE (Egyptian Joint Stock Company)
Issued
Capital : £E 27,500,000
Paid
up Capital : £E 27,500,000
Name of Shareholder (s) Percentage
· Dr. George Sabet
Bassily 83%
· Dr. Ezzat Halim
Boutros 9%
· Alfa Chem for
Pharmaceutical 8%
Note to the Legal Form
The Egyptian Company Law provides that the capital of a Societe Anonyme Egyptienne - SAE – should not be less than £E 500,000 if shares are offered to the public and £E 250,000 if not. If shares are offered to the public they are freely transferable, if not, transfer may be restricted. Liability of shareholders is limited.
LINE OF BUSINESS
Operations
: Engaged in the manufacture and export of human
pharmaceuticals.
Import
Countries :
India and Japan
Export
Countries : Yemen and Sudan
Subject
has a workforce of approximately 350 employees.
FINANCIAL HIGHLIGHTS
Companies
registered in Egypt are not legally required to make their accounts public and
no financial information was released by the company or submitted by outside
sources.
BANKERS
·
National
Bank of Egypt
24, Sherif Street
Cairo
Tel : (20-2) 3924175
Fax : (20-2) 3924143
PAYMENT HISTORY
No
complaints regarding subject’s payments have been reported.
GENERAL COMMENTS
Opinion
on the credit figure of US$ 100,000
During
the course of this investigation nothing detrimental was uncovered regarding
subject’s operating history or the manner in which payments are fulfilled. As
such the company is considered to be a fair trade risk and the above credit
figure is within subject’s financial means.
Maximum
suggested credit figure: US$ 750,000
RATING EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
>86 |
Aaa |
Possesses an extremely sound financial
base with the strongest capability for timely payment of interest and
principal sums |
Unlimited |
|
71-85 |
Aa |
Possesses adequate working capital. No
caution needed for credit transaction. It has above average (strong)
capability for payment of interest and principal sums |
Large |
|
56-70 |
A |
Financial & operational base are
regarded healthy. General unfavourable factors will not cause fatal effect.
Satisfactory capability for payment of interest and principal sums |
Fairly Large |
|
41-55 |
Ba |
Overall operation is considered normal.
Capable to meet normal commitments. |
Satisfactory |
|
26-40 |
B |
Unfavourable & favourable factors
carry similar weight in credit consideration. Capability to overcome
financial difficulties seems comparatively below average/normal. |
Small |
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of
interest and principal sums in default or expected to be in default upon
maturity |
Limited with full security |
|
<10 |
C |
Absolute credit risk exists. Caution
needed to be exercised |
Credit not recommended |
|
NR |
In view of the lack of information, we
have no basis upon which to recommend credit dealings |
No Rating |
|